To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure patients have access to (a) oestrogen and (b) testosterone HRT implants in the context of supply difficulties from the US.

Oestrogen and testosterone hormone replacement therapy (HRT) implants are not licenced in the United Kingdom. The Department is working closely with the Medicines and Healthcare products Regulatory Agency (MHRA) to ensure safe access to these products. We have also reached out to specialist importers who can source unlicensed medicines in order to find alternative sources of both HRT implants for UK patients. We will continue to work closely with the MHRA and the National Health Service to ensure suitable alternatives are available for patients.